left ventricular systolic dysfunction
Agency for Health Care       Policy and Research, the American College of Cardiology/American Heart       Association Task Force on Practice Guidelines, and the Task Force of the Working        Group on Heart Failure of the European Society of Cardiology--supported by the       results of numerous large-scale randomized controlled trials--define the standard       universal pharmacologic approach to all patients with left ventricular systolic       dysfunction.
Agency for Health Care       Policy and Research, the American College of Cardiology/American Heart       Association Task Force on Practice Guidelines, and the Task Force of the Working        Group on Heart Failure of the European Society of Cardiology--supported by the       results of numerous large-scale randomized controlled trials--define the standard       universal pharmacologic approach to all  @OBJECT$   @PREDICAT$   @SUBJECT$ .